Trinity Capital Inc
NASDAQ:TRIN

  • LAST PRICE
    14.8800
  • TODAY'S CHANGE (%)
    -0.0250 (-0.1677%)
  • Bid / Lots
    14.8900/ 1
  • Ask / Lots
    14.9800/ 40
  • Open / Previous Close
    14.9500 / 14.9050
  • Day Range
    14.8200
    14.9753
  • 52 Week Range
    11.6200
    15.4400
  • Volume
    306,882

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Yesterday

      Show headlines and story abstract

    • 16 hours ago by PR Newswire
      Companies Mentioned: TRIN

      Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility. This significant investment, of which an initial $42.5 million was funded at closing, will be utilized to fuel the company's growth initiatives and expand its research and development efforts to further enhance its metabolomics platform. The investment will also support the company's global expansion plans, including market penetration initiatives and strategic partnerships.

    • 16 hours ago by Dow Jones
      Companies Mentioned: TRIN

      Metabolon Secures $60 Million Credit Facility to Drive Growth and Innovation

      PR Newswire

      MORRISVILLE, N.C., May 16, 2024

      MORRISVILLE, N.C., May 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility. This significant investment, of which an initial $42.5 million was funded at closing, will be utilized to fuel the company's growth initiatives and expand its research and development efforts to further enhance its metabolomics platform. The investment will also support the company's global expansion plans, including market penetration initiatives and strategic partnerships.

    • 16 hours ago by Dow Jones
      Companies Mentioned: TRIN

      Metabolon Secures $60 Million Credit Facility to Drive Growth and Innovation

      PR Newswire

      MORRISVILLE, N.C., May 16, 2024

      MORRISVILLE, N.C., May 16, 2024 /PRNewswire/ -- Metabolon, Inc., the global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications, announced that it has closed on a new $60 million credit facility. This significant investment, of which an initial $42.5 million was funded at closing, will be utilized to fuel the company's growth initiatives and expand its research and development efforts to further enhance its metabolomics platform. The investment will also support the company's global expansion plans, including market penetration initiatives and strategic partnerships.

    • 16 hours ago by PR Newswire
      Companies Mentioned: TRIN

      Trinity Capital Inc.(NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $60 million in growth capital to Metabolon, a global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications.

    • 16 hours ago by Dow Jones
      Companies Mentioned: TRIN

      Trinity Capital Inc. Provides $60 Million in Growth Capital to Metabolon

      PR Newswire

      PHOENIX, May 16, 2024

      PHOENIX, May 16, 2024 /PRNewswire/ -- Trinity Capital Inc. (NASDAQ: TRIN) ("Trinity"), a leading provider of diversified financial solutions to growth-stage companies, today announced the commitment of $60 million in growth capital to Metabolon, a global leader in providing metabolomics solutions advancing a wide variety of life science research, diagnostic, therapeutic development, and precision medicine applications.

Peers Headlines